Cargando…
Multiple receptor conversions during the course of metastatic breast cancer therapy: a case report and review of the literature
BACKGROUND: Adjuvant systemic therapy decreases recurrence and death from breast cancer, but late relapse still occurs. Therapeutic decisions are based heavily on receptor tissue characterization. Even though the vast majority of metastatic sites do not have receptor conversions, they can occur at t...
Autores principales: | Chamorro, Yolcar, Sandoval-Leon, Ana C., Vogel, Charles L., Nguyen, Michaela T., Wang, Grace |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746084/ https://www.ncbi.nlm.nih.gov/pubmed/36510266 http://dx.doi.org/10.1186/s13256-022-03679-y |
Ejemplares similares
-
Receptor conversion in metastatic breast cancer: a prognosticator of survival
por: Meng, Xiangying, et al.
Publicado: (2016) -
Clinical relevance of receptor conversion in metastatic breast cancer: Case report
por: Silva, Diogo J., et al.
Publicado: (2022) -
Receptor conversion in distant breast cancer metastases
por: Hoefnagel, Laurien DC, et al.
Publicado: (2010) -
Efficacy and safety analysis in metastatic cancer patients treated with multiple courses of repeat radiation therapy
por: Ahmadsei, Maiwand, et al.
Publicado: (2023) -
5th Course on Solar-energy Conversion
por: Dixon, A E, et al.
Publicado: (1979)